Tuesday, January 25, 2022
News

Expert panel recommends restricted emergency use nod to Bharat Biotech's COVID-19 vaccine

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

By Priyanka Sharma

New Delhi | January 2, 2021 8:12:53 PM IST
An expert panel of Drugs Controller General of India (DCGI) has recommended granting restricted emergency use authorisation to Bharat Biotech's indigenously developed COVID-19 vaccine, also known as Covaxin, government sources told ANI on Saturday.

"Expert panel has recommended granting permission for restricted emergency use authorisation for Bharat Biotech's indigenously developed COVID-19 vaccine," a source said.

The meeting of Subject Expert Committee (SEC) meeting of Drugs Controller General of India (DCGI) was held in Delhi on Friday to review the application submitted by two companies - SII and Bharat Biotech- who had applied to get the emergency use authorisation (EUA) for their vaccine candidates.

Covaxin is an indigenously developed coronavirus vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR). (ANI)

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
Bal Puraskar awards comes with huge resp...
Traditional dry fish Hogard in great dem...
PM Modi says proud to see young Indians ...
Cold wave to intensify in Delhi after Ja...
Uttarakhand polls: Harish Rawat set to c...
UP TET: One held for impersonating candi...
More...    
 
 Top Stories
Afghanistan's National Resistance F... 
Delhi reports 5,760 new COVID-19 ca... 
China uses strict measures to count... 
PKL: Defence helps Puneri Paltan de... 
VO Chidambaranar Port handles longe... 
RBI imposes monetary penalty on 8 c... 
If voted to power in Punjab, AAP go... 
Pakistan Peoples Party announces ma...